| Issue Date | Title | Author(s) |
| 2021 | Valproic Acid Regulates HR and Cell Cycle Through MUS81-pRPA2 Pathway in Response to Hydroxyurea. | Su, B; Lim, D; Tian, Z; Liu, G; Ding, C; Cai, Z; Chen, C; Zhang, F; Feng, Z |
| 2023-02 | Valproic acid as a radio-sensitizer in glioma: A systematic review and meta-analysis. | Sullivan, JK; Fahey, PP; Agho, KE; Hurley, SP; Feng, Z; Day, RO; Lim, D |
| 2023-03-14 | Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000-2014 (CONCORD-3). | Girardi, F; Matz, M; Stiller, C; You, H; Marcos Gragera, R; Valkov, MY; Bulliard, J-L; De, P; Morrison, D; Wanner, M; O'Brian, DK; Saint-Jacques, N; Coleman, MP; Allemani, C; CONCORD Working Group, |
| 2023-03 | Is being able to walk to the letterbox life-changing? A qualitative assessment of measures of improvement in persistent breathlessness. | Ferreira, DH; Ekström, M; Verberkt, C; Janssen, DJA; Currow, DC |
| 2023-01-01 | Treatment and Survival in Acute Leukemia: A New South Wales Study Comparing Adolescents and Young Adults with Children and Adults | Li, M; Anazodo, A; Dalla-Pozza, L; Baeza, PK; Roder, D; Currow, D; Batra, L |
| 2023-10 | The effect of general practice contact on cancer stage at diagnosis in Aboriginal and non-Aboriginal residents of New South Wales. | Banham, D; Roder, D; Thompson, S; Williamson, A; Bray, F; Currow, D |
| 2023-10 | Exploring the clinical utility of a brief screening measure of unmet supportive care needs in people with high-grade glioma. | Campbell, R; Faris, M; Shaw, J; Halkett, GKB; Legge, D; Koh, E-S; Nowak, AK; Agar, MR; Ownsworth, T; Pike, KE; Chan, RJ; Dhillon, HM |
| 2024-01 | Are Published Cancer Care Trial Protocols With Traditional Chinese Medicine Interventions Concordant With SPIRIT-TCM Extension 2018? A Scoping Review on Published Trial Protocols Between 2019 and 2022 | Lai, H; Yang, P; Wang, XS; Lim, D; Lam, A; Shi, Y; Huang, Y; Zhu, X |
| 2023-06-01 | Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain | Matsuoka, H; Clark, K; Fazekas, B; Oyamada, S; Brown, L; Ishiki, H; Matsuda, Y; Hasuo, H; Ariyoshi, K; Lee, J; Le, BH; Fujiwara, N; Miyaji, T; Agar, MR; Yamaguchi, T; Satomi, E; Iwase, S; Phillips, J; Koyama, A; Currow, DC |
